Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Trametinib

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGEAY131-M

    07/16/2015

    Molecular Analysis for Therapy Choice

    Treatment

    VICCMEL1471

    02/04/2015

    A Phase 1b/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 232 Combined with Trametinib and Dabrafenib or Trametinib in Adult Subjects with Metastatic Cutaneous Melanoma

    Treatment

    VICCMEL1457

    01/19/2015

    A Phase II Open-Label, Two-Arm Study of the MEK Inhibitor, Trametinib, to Investigate the Safety and Anti-Cancer Activity in Subjects with Melanoma with BRAF non-V600 Mutations


    Print this page for your doctor